Pending

Rare case of type B insulin resistance in association with systemic lupus erythematosus: illustrating diagnostic and management challenges
Antitumor Necrosis Factor-Alpha (TNF-alpha) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn’s Disease
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics
Follicular Regulatory T Cells in Systemic Lupus Erythematosus
Neuropsychiatric Lupus: A Challenging Journey of a Patient With Pulmonary Tuberculosis
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics
Neuropsychiatric Lupus: A Challenging Journey of a Patient With Pulmonary Tuberculosis
Follicular Regulatory T Cells in Systemic Lupus Erythematosus
Antitumor Necrosis Factor-Alpha (TNF-alpha) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn’s Disease
Systemic lupus erythematosus complicated with reversible posterior encephalopathy syndrome: a case report
Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus
Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention
Dependence on Autophagy for Autoreactive Memory B Cells in the Development of Pristane-Induced Lupus
Lupus Nephritis with Obvious IgA deposits in the Kidneys
Lupus-related protein-losing enteropathy associated with pseudo-pseudo Meigs’ syndrome and successfully treated with hydroxychloroquine
Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory models
Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre
Successful treatment of tinea capitis caused by Microsporum canis in a 23-day-old newborn with itraconazole pulse therapy and a review of the literature
The Effectiveness of Walking in Patients With Systemic Lupus Erythematosus
Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review
Suitability for e-health of non-pharmacological interventions in connective tissue diseases: scoping review with a descriptive analysis
A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells
Disseminated Herpes Zoster on a Child with Systemic Lupus Erythematosus and Lupus Nephritis
Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus
An evaluation of a novel nanoformulation of imatinib mesylate in a mouse model of lupus nephritis
Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort
Unsupervised clustering analysis of data from an online community to identify lupus patient profiles with regards to treatment preferences
Cf-02, a novel benzamide-linked small molecule, blunts NF-kappaB activation and NLRP3 inflammasome assembly and improves acute onset of accelerated and severe lupus nephritis in mice
Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed”
Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-delta Syndrome 2 in an Adult Patient
RNA Methylation in Systemic Lupus Erythematosus
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Clinical characteristics and risk factors in 118 patients with systemic lupus erythematosus and osteonecrosis
Immature platelet levels correlate with disease activity and predict treatment response of thrombocytopenia in lupus patients
Treatment outcomes in refractory lupus nephritis: Data from an observational study
Hydrogen Sulfide: a Novel Immunoinflammatory Regulator in Rheumatoid Arthritis
Lupus clinical trial eligibility in a real-world setting: results from the British Isles Lupus Assessment Group-Biologics Register (BILAG-BR)
Effects of Atorvastatin on T-Cell Activation and Apoptosis in Systemic Lupus Erythematosus and Novel Simulated Interactions With C-Reactive Protein and Interleukin 6
A functionally improved case of obstructive impairment caused by systemic lupus erythematosus
Elevation of serum fibroblast growth factor 23 level in a pediatric patient with lupus nephritis
Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study
Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands(+) Macrophages via Activating IL-4/STAT6/PD-L2 Signaling
Comprehension, Utility, and Acceptability of a Multi-Domain Physical Functioning Report for Systemic Lupus Erythematosus Patients and Their Providers
Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus
Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses
IRF-8/miR-451a regulates M-MDSC differentiation via the AMPK/mTOR signal pathway during lupus development
Axonal dysfunction is associated with interferon-gamma levels in childhood-onset systemic lupus erythematosus: a multivoxel magnetic resonance spectroscopy study
Topical Corticosteroids
Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis
Chloroquine
Brachytherapy
International Consensus For The Dosing Of Corticosteroids In Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis
Distinct Microbiomes of Gut and Saliva in Patients With Systemic Lupus Erythematous and Clinical Associations
The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients
A Case of COVID-19 Mimicking Acute Appendicitis in Multi-System Inflammatory Syndrome
Liver Abnormalities in Systemic Lupus Erythematosus: A Prospective Observational Study
Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis
Parasite-based interventions on systemic lupus erythematosus (SLE): A systematic review
Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
Mesenchymal stem cells: ideal seeds for treating diseases
Isotopic response of labetalol-associated lichen planus pemphigoides on an old radiation site: a case report
Lupus mastitis: A rare breast cancer differential diagnosis
Systemic Lupus Erythematosus with Crohn’s Disease: A Rare Combination and Unusual Presentation
Cognitive impairment in systemic lupus erythematosus is negatively related to social role participation and quality of life: A systematic review
Five years follow-up of Juvenile lupus nephritis: a single-center retrospective cohort study
Case Report: Predominant Tubulointerstitial Lupus Nephritis or the Combination With IgG4-Related Disease?
A systematic review and meta-analysis: effects of glucocorticoids on rheumatoid arthritis and systemic lupus erythematosus
Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus
Disease course following High Disease Activity Status revealed patterns in SLE
Altered Profile of Fecal Microbiota in Newly Diagnosed Systemic Lupus Erythematosus Egyptian Patients
Fatal cerebral venous sinus thrombosis as a manifestation of uncontrolled systemic lupus erythematosus in a young African female
Subacute cutaneous lupus erythematosus following abemaciclib therapy for metastatic breast cancer
A case of reversible cerebral vasoconstriction syndrome associated with anti-phospholipid antibody syndrome and systemic lupus erythematosus
A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care
The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations
Incorporating Unstructured Patient Narratives and Health Insurance Claims Data in Pharmacovigilance: Natural Language Processing Analysis of Patient-Generated Texts About Systemic Lupus Erythematosus
LUPUS-BEST-treat-to-target in systemic lupus erythematosus: study protocol for a three-armed cluster-randomised trial
A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus
Efficacy of cyclosporine in a patient with lupus mesenteric vasculitis refractory to conventional immunosuppressive therapy
Perinatal Management and Long-Term Follow-up of a Primipara With Severe Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus
Lupus Miliaris Disseminatus Faciei versus Granulomatous Rosacea: A Case Report
Case Report: Psychopathological Syndromes in the Course of Lupus Erythematosus and the Co-occurrence of Lupus Erythematous With Mental Disorders
An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus
Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus
T cell receptor revision and immune repertoire changes in autoimmune diseases
Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus
Investigation of Newly Diagnosed Drug-Naive Patients with Systemic Autoimmune Diseases Revealed the Cleaved Peptide Tyrosine Tyrosine (PYY 3-36) as a Specific Plasma Biomarker of Rheumatoid Arthritis
Acute Pyogenic Osteomyelitis of the Pubic Bone in a Patient with Systemic Lupus Erythematosus Mimicking Fracture of the Pubic Bone and Periprosthetic Joint Infection of the Hip
Can we predict if patients will require more than one cycle of rituximab?
Impaired function of PD-1+ follicular regulatory T cells in systemic lupus erythematosus
Prevalence of periapical abscesses in patients with systemic lupus erythematosus
Belimumab In Treatment of Early Systemic Lupus Erythematosus
10 Years of belimumab experience: What have we learnt?
The impact of antimalarial agents on traditional and non-traditional subclinical atherosclerosis biomarkers in systemic lupus erythematosus: A systematic review and meta-analysis
Pembrolizumab related Guillain barre syndrome, a rare presentation in a patient with a history of lupus and bladder cancer
TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases
Rituximab induced acute thrombocytopenia in a patient with systemic lupus erythematosus: a case report
Role of epoxide hydrolases and cytochrome P450s on metabolism of KZR-616, a first-in-class selective inhibitor of the immunoproteasome
A Case of Subacute Cutaneous Lupus Erythematosus and Review of Cutaneous Lupus Clinical Variants

Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients
An Imperfect Marker: SLE and TTP-Like MAHA Without Low ADAMTS13
Hydroxychloroquine alleviates the neurotoxicity induced by anti-ribosomal P antibodies
Kidney transplantation outcomes in lupus nephritis: A 37-year single-center experience from Latin America
Therapeutic plasma exchange for anticoagulant-refractory antiphospholipid syndrome with severe ischemic and necrotic skin lesions: A case series
Hidden mysteries behind genome, epigenome, and exposome of lupus erythematosus
IFN-α: a key therapeutic target for multiple autoimmune rheumatic diseases
Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort
A novel computational drug repurposing approach for Systemic Lupus Erythematosus (SLE) treatment using Semantic Web technologies
Integrated Transcriptome Profiling Revealed That Elevated Long Non-Coding RNA-AC007278.2 Expression Repressed CCR7 Transcription in Systemic Lupus Erythematosus
Pregnancy Outcomes in Systemic Lupus Erythematosus Women: A single tertiary centre experience
Comprehensive Analysis of Clinical Trials Registration for Lupus Nephritis Therapy on ClinicalTrials.gov
Alport syndrome combined with lupus nephritis in a Chinese family: A case report
5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivative attenuates lupus nephritis with less effect to thymocyte development
The PI3Kdelta inhibitor parsaclisib ameliorates pathology and reduces autoantibody formation in preclinical models of systemic lupus erythematosus and Sjgren’s syndrome
Risk factors for the flare of systemic lupus erythematosus and its influence on prognosis: a single-center retrospective analysis
Interferons in Systemic Lupus Erythematosus
Neutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus
T Cells in Systemic Lupus Erythematosus
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus
Lupus Cohorts
Innovative Trials and New Opportunities in SLE
Treatment Update in Systemic Lupus Erythematous
Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea
Dietary Supplementation With Eicosapentaenoic Acid Inhibits Plasma Cell Differentiation and Attenuates Lupus Autoimmunity
Strategies to Use Nanoparticles to Generate CD4 and CD8 Regulatory T Cells for the Treatment of SLE and Other Autoimmune Diseases
A case of neuromyelitis optica spectrum disorder with coexisting systemic lupus erythematosus
Updates on Clinical Trials in Systemic Lupus Erythematosus
Targeting Intra-Pulmonary P53-Dependent Long Non-Coding RNA Expression as a Therapeutic Intervention for Systemic Lupus Erythematosus-Associated Diffuse Alveolar Hemorrhage
Computational-Driven Epitope Verification and Affinity Maturation of TLR4-Targeting Antibodies
Factors affecting the resolution of acute non-infectious anterior scleritis
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia
Patterns of Medication Use in Systemic Lupus Erythematosus – A Multi-Centre Cohort Study
Palate Tuberculosis with Paradoxical Lymphadenitis
SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case
Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus
A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants
Severe diarrhea in a 10-year-old girl with Aicardi-Goutières syndrome due to IFIH1 gene mutation
The role of CD8+ T-cell systemic lupus erythematosus pathogenesis: an update
Treatment-resistant acute upper limb ischemia in a patient with Systemic Lupus Erythematous and concomitant SARS-CoV-2 infection: a case report
Function, occurrence and inhibition of different forms of BAFF
Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy
Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis
A young girl with chronic isolated cervical lymphadenopathy found to have lupus lymphadenopathy, progressing to develop lupus nephritis: a case report
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report
Gastrointestinal involvement in systemic lupus erythematosus: A systematic review
Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus: comparison between renal and non-renal involvement
Recurrent respiratory arrests – an unusual manifestion of SLE
Ovarian vein thrombosis in the postnatal period
Serum levels of n-3 and n-6 polyunsaturated fatty acids in patients with systemic lupus erythematosus and their association with disease activity: a pilot study
British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus (CLE) 2021
Estimation of Prevalence and Incremental Costs of Systemic Lupus Erythematosus in a Middle-Income Country Using Machine Learning on Administrative Health Data
Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4+ T Cells in Type 1 Diabetes
Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey
EMBRACE: Phase 3/4, Randomized, 52-Week Study of Belimumab Efficacy and Safety in Patients of Black African Ancestry With Systemic Lupus Erythematosus
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients
When and How Is it Possible to Stop Therapy in Patients with Lupus Nephritis?
Scurvy mimicking as systemic lupus erythematosus
Identification of hub genes, pathways, and related transcription factors in systemic lupus erythematosus: A preliminary bioinformatics analysis
Lupus nephritis and ANCA-associated vasculitis: towards precision medicine?
Treatments for Disease Damage in Cutaneous Lupus Erythematosus: A Narrative Review
Effects of alternative remission criteria on outcome of pediatric proliferative lupus nephritis: a multi-center retrospective study of pediatric proliferative lupus nephritis
Novel Long Non-coding RNA Expression Profile of Peripheral Blood Mononuclear Cells Reveals Potential Biomarkers and Regulatory Mechanisms in Systemic Lupus Erythematosus
The interplay between tumor necrosis factor alpha, disease activity, and depressive symptoms among Egyptian female patients with systemic lupus erythematosus
Improvement of renal and non-renal SLE outcome measures on sirolimus therapy – A 21-year follow-up study of 73 patients
Clinical and laboratory features, disease activity, and outcomes of juvenile systemic lupus erythematosus at diagnosis: a single-center study from southern China
Mycophenolic Acid Exposure Optimization Based on Vitamin D Status in Children with Systemic Lupus Erythematosus: A Single-Center Retrospective Study
Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)
Comparison of plasma levels and immunoactivities of different forms of circulating-free DNA in systemic lupus erythematosus patients
Severe lupus induced by the tumor necrosis factor-alpha inhibitor Anbainuo: a case report
A case report: paroxysmal nocturnal hemoglobinuria and systemic lupus erythematosus association
A Review of the Efficacy of Influenza Vaccination in Autoimmune Disease Patients
Neuropsychiatric lupus with posterior reversible encephalopathy syndrome: a rare presentation
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus
The other connective tissue disease-associated interstitial lung diseases: Sjogren’s syndrome, mixed connective tissue disease, and systemic lupus erythematosus
Meant to B: B cells as a therapeutic target in systemic lupus erythematosus
Depletion of Fractalkine ameliorates renal injury and Treg cell apoptosis via the p38MAPK pathway in lupus-prone mice
Kidney Transplantation and Cardiovascular Events Among Patients with End-Stage Renal Disease due to Lupus Nephritis: A Nationwide Cohort Study
Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus
Acquired White Oral Lesions with Specific Patterns: Oral Lichen Planus and Lupus Erythematosus
Metformin Reverses Hashimoto’s Thyroiditis by Regulating Key Immune Events
Current Status of the Evaluation and Management of Lupus Patients and Future Prospects
Cholinergic anti-inflammatory pathway and connective tissue diseases
SLE strikes the heart! A rare presentation of SLE myocarditis presenting as cardiogenic shock
A Phase 2 of VIB7734 for the Treatment of Moderate to Severely Active SLE
Autoimmunity and COVID-19 – The microbiotal connection
Therapeutic potential of targeting Tfr/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study
Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond
A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis
Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review
Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus Erythematosus
IRE1alpha-mediated monounsaturated fatty acid synthesis drives B cell differentiation and lupus-like autoimmune disease
Cardiovascular disease prevention in individuals with underlying chronic inflammatory disease
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report
Increased TIM-3(+)PD-1(+) NK cells are associated with the disease activity and severity of systemic lupus erythematosus
Adipose Grafting for Volume and Scar Release
Spontaneous intracranial hypotension: A rare cause of headache in systemic lupus erythematosus
The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?
Personal Precise Treatment on Psoriasis and Psoriatic Arthritis

Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy
Effects of Peptide-Induced Immune Tolerance on Murine Lupus
Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p
Sustained low-dose interleukin-2 therapy alleviates pathogenic humoral immunity via elevating the Tfr/Tfh ratio in lupus
Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature
CircELK4 Contributes to Lupus Nephritis by Acting as a miR-27b-3p Sponge to Regulate STING/IRF3/IFN-I Signaling
Myxomavirus serpin alters macrophage function and prevents diffuse alveolar hemorrhage in pristane-induced lupus
Acute acalculous cholecystitis as the initial manifestation of systemic lupus erythematous: A case report
Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report
The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell Resolution
Successful treatment of pulmonary aspergillosis due to Aspergillus fumigatus in a child affected by systemic lupus erythematosus: A case report from Northeastern Iran
Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study
Long-term immunosuppression and multiple transplants predispose systemic lupus erythematosus patients with cytopenias to hematologic malignancies
miRNA-Mediated Control of B Cell Responses in Immunity and SLE
A case report of a boy suffering from type 1 diabetes mellitus and familial Mediterranean fever
Targeting of Deciduous Tooth Pulp Stem Cell-Derived Extracellular Vesicles on Telomerase-Mediated Stem Cell Niche and Immune Regulation in Systemic Lupus Erythematosus
B cells as target for immunotherapy in rheumatic diseases – current status
Shared genetic study gives insights into the shared and distinct pathogenic immunity components of IgA nephropathy and SLE
Antiretroviral Therapy Improves Acquired Immunodeficiency Syndrome with Systemic Lupus Erythematosus
Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
CD47 Potentiates Inflammatory Response in Systemic Lupus Erythematosus
Lupus erythematosus tumidus in a patient with mycosis fungoides stage IB after complete response to PUVA
Case of vaso-occlusive retinopathy in Kikuchi-Fujimoto and lupus overlap syndrome
Association Between Myasthenia Gravis and Systemic Lupus Erythematosus as a Comorbid State
Hydroxychloroquine does not impair antibody response to 13-valent pneumococcal conjugate vaccine in patients with cutaneous lupus erythematosus – a pilot study
Isolation, behavioral changes and low seroprevalence of SARS-CoV-2 antibodies in patients with Systemic Lupus Erythematosus or Rheumatoid arthritis
Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy
Immune thrombocytopenia and COVID-19: Case report and review of literature
Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus
Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)
IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus
Clinico-Laboratory Features and Associated Factors of Lupus Mesenteric Vasculitis
Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey
Factors associated with self-reported capacity to walk, jog and run in individuals with systemic lupus erythematosus
Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor, Fenebrutinib (GDC-0853), in Systemic Lupus Erythematosus
What Did Not Work: The Drug or the Trial?
Neuropsychiatric Events in Systemic Lupus Erythematosus
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus
REDOX CONTROL OF INTEGRIN-MEDIATED HEPATIC INFLAMMATION IN SYSTEMIC AUTOIMMUNITY
Cytomegalovirus-Associated Hemolytic Anemia in an Infant Born to a Mother with Lupus
Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases
Overview of therapeutic applications of non-invasive vagus nerve stimulation: a motivation for novel treatments for systemic lupus erythematosus
Systemic lupus erythematosus presenting as non-resolving pneumonia: a case report
Does systemic lupus erythematosus increase the risk of complications from total hip arthroplasty?
Investigation of the effect of Huaiqihuang granules via adjuvant treatment in children with relapsed systemic lupus erythematosus
Changes of serum IL-6, IL-10 and TNF-alpha levels in patients with systemic lupus erythematosus and their clinical value
Effects of two blood purification treatments combined with immunosuppressants on GM-CSF and CXCL16 levels in patients with lupus nephritis
What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts
Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study
Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus
Skin reaction to capsaicin in patients with systemic lupus erythematosus compared to healthy controls
Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke
Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus
Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis
The complex role of AIM2 in autoimmune diseases and cancers
A Study Evaluating the Efficacy and Safety of BMS-986256 Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care
Therapeutic Strategies of Neuropsychiatric Systemic Lupus Erythematosus
Simultaneous Onset of Mycobacterium kansasii Pulmonary Infection and Systemic Lupus Erythematosus: A Case Report
A Model About the Response of Belimumab in SLE
Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis
Plasma microparticles from patients with Systemic Lupus Erythematosus modulate the content of miRNAs in U937 cells
A significant improvement of thromboses treated by a new oral anticoagulant in an 11-year-old girl with systemic lupus erythematosus associated antiphospholipid syndrome: A case report
Clinical characteristics of cerebral venous sinus thrombosis in childhood-onset systemic lupus erythematosus patients: a single-centre study from China
Therapeutic responses and predictors of low-dose interleukin-2 in systemic lupus erythematosus
Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements
Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis
Lupus-Mediated Kidney Damage: Lupus Nephritis or Collapsing Glomerulopathy?
Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management
Clinical Characteristics and Prognosis of Renal Thrombotic Microangiopathy in Lupus Nephritis
Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus
Few Adverse Cardiovascular Events among Patients with Rheumatoid Arthritis Receiving Hydroxychloroquine: Are We Reassured?
Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus
The Care-coordination Approach to Learning Lupus Self-Management: a patient navigator intervention for systemic lupus inpatients
Conjunctival Chemosis and Annular Ciliochoroidal Detachments Detected by Anterior-Segment Optical Coherence Tomography in a Case of Systemic Lupus Erythematosus
Cerebral venous sinus thrombosis and subdural hematoma in a female patient with systemic lupus erythematosus: a case report and literature review
Lupus-like membranous nephropathy. Is it lupus? Report of 5 cases in a reference hospital in Mexico
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
Severe cutaneous presentation of hydralazine-induced ANCA vasculitis without renal or pulmonary involvement, complicated by DIC
Genetic and immunologic findings in children with recurrent aphthous stomatitis with systemic inflammation
A new old treatment for lupus nephritis
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
A new challenge of lupus nephritis management: Induction therapy without immunosuppressive maintenance regimen
Emerging role of galectin family in inflammatory autoimmune diseases
Lupus anticoagulant-hypoprothrombinaemia syndrome: subdural haematoma as an unusual and initial manifestation
A case of HIV negative cryptococcal meningitis with antiphospholipid syndrome
Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient
Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus
Systemic lupus erythematosus complicated by Crohn’s disease with rectovaginal fistula
Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada
IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis
Granulocyte colony-stimulating factor is not pathogenic in lupus nephritis
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
Phase 2, Randomized, Placebo-Controlled Trial of Dapirolizumab Pegol in Patients with Moderate-to-Severe Active Systemic Lupus Erythematosus
Adult systemic lupus erythematosus in Egypt: The nation-wide spectrum of 3661 patients and world-wide standpoint
Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study

Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review
Perfusion image guided mechanical thrombectomy combined with tirofiban successfully revascularize systemic lupus erythematosus related acute large vessel occlusion: A case report
Exploring the role of immunotherapeutic drugs in autoimmune diseases: A comprehensive review
Successful treatment of two cases of refractory cutaneous lupus erythematosus with belimumab
Curcumin, autoimmune and inflammatory diseases: going beyond conventional therapy – a systematic review
Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future)
Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
Systemic Lupus Erythematosus Complicated with Hypertrophic Cardiomyopathy: A Case Report and Literature Review
The Impact of Serum Anti-neutrophil Cytoplasmic Antibody on Clinical Characteristics and Outcomes in Pediatric-Onset Systemic Lupus Erythematosus Patients
Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus
T cell plasticity in renal autoimmune disease
Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation
Daratumumab to Treat Active Lupus Nephritis
Transcription Factor Activity Inference in Systemic Lupus Erythematosus
Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus
Lupus Pneumonitis Therapy Masks Coronavirus (COVID-19)
Systemic Administration of alpha7-Nicotinic Acetylcholine Receptor Ligands Does Not Improve Renal Injury or Behavior in Mice With Advanced Systemic Lupus Erythematosus
Infantile systemic lupus erythematous presenting as nephrotic syndrome in a 12-month-old boy: a case report
Recurrent pericarditis associated with human coronavirus (HKU1) infection in a patient with systemic lupus erythematosus (SLE)
Advances in Lupus Nephritis Pathogenesis: From Bench to Bedside
Lipopolysaccharide-Enhanced Responses against Aryl Hydrocarbon Receptor in FcgRIIb-Deficient Macrophages, a Profound Impact of an Environmental Toxin on a Lupus-Like Mouse Model
Urinary Peptides as Potential Non-Invasive Biomarkers for Lupus Nephritis: Results of the Peptidu-LUP Study
Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases
Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
Anxiety and depression severity in neuropsychiatric SLE are associated with perfusion and functional connectivity changes of the frontolimbic neural circuit: a resting-state f(unctional) MRI study
Palisaded Neutrophilic and Granulomatous Dermatitis in a Patient with Behcet’s Disease: A Case Report
Aberrant Gut Microbiome Contributes to Intestinal Oxidative Stress, Barrier Dysfunction, Inflammation and Systemic Autoimmune Responses in MRL/lpr Mice
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
What Does it Mean to be a British Isles Lupus Assessment Group-Based Composite Lupus Assessment Responder? Post Hoc Analysis of 2 Phase 3 Trials
Causes and predictors of mortality from lupus nephritis in Southern Hunan, China
Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis
Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Regulate Macrophage Polarization to Attenuate Systemic Lupus Erythematosus-Associated Diffuse Alveolar Hemorrhage in Mice
Anorexia nervosa and juvenile lupus erythematosus in a 16-year-old female patient – common disease origin or random coincidence?
Omega-3 Polyunsaturated Fatty Acid Intervention Against Established Autoimmunity in a Murine Model of Toxicant-Triggered Lupus
Is Lupus Nephritis a Prognosis Factor for Pregnancy? Maternal and Foetal Outcomes
An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review
Successful Treatment with Belimumab in a Patient with Refractory Systemic Lupus Erythematosus after Initiation of Hemodialysis: Considering the Synergistic Effect of Belimumab and Immunological Burn-Out Phenomenon in End-Stage Renal Disease Patients on Hemodialysis
Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities
Learning from imbalanced fetal outcomes of systemic lupus erythematosus in artificial neural networks
Frequency of Systemic Lupus Erythematosus Was Decreasing Among Hospitalized Patients From 2013 to 2017 in a National Database in China
Predictors of Infection in Children with Systemic Lupus Erythematosus: A Single Center Study in Indonesia
Stress, Inflammation and Immune Response Pilot Study- Aim 3
A Study to Evaluate Efficacy and Safety of BMS-986165 in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Shrinking lung syndrome in pediatric systemic lupus erythematosus
Interferon-alpha activates interleukin-1 receptor-associated kinase 1 to induce regulatory T-cell apoptosis in patients with systemic lupus erythematosus
Th cytokine profile in childhood-onset systemic lupus erythematosus
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’
Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study
Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature
Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis
Immune profiling of lupus miliaris disseminatus faciei and successful management with anti-TNF therapy
Azithromycin alleviates systemic lupus erythematosus via the promotion of M2 polarisation in lupus mice
Gut Microbiota in Lupus: a Butterfly Effect?
5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model
Etanercept prevents TNF-alpha mediated mandibular bone loss in FcgammaRIIb-/- lupus model
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
TRIM27 contributes to glomerular endothelial cell injury in lupus nephritis by mediating the FoxO1 signaling pathway
cGAS-STING Pathway Does Not Promote Autoimmunity in Murine Models of SLE
Weighted Gene Co-expression Network Analysis Reveals Different Immunity but Shared Renal Pathology Between IgA Nephropathy and Lupus Nephritis
Associations between glucocorticoids, antiphospholipid antibodies and femur head necrosis in patients with SLE: a directed acyclic graph-based multicentre study
Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis
Exercise alleviates symptoms of CNS lupus
Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor
The Benefits of Complement Measurements for the Clinical Practice
Detection of Anti-C3b Autoantibodies by ELISA
Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus
Lupus Cerebritis Refractory to Guideline-Directed Therapy: A Case Report
One year in review 2021: systemic lupus erythematosus
The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity
Lupus erythematosus associated with erythema multiforme or Rowell’s syndrome. Report of one case
Contribution of Clinically Indicated Repeat Renal Biopsy in Indian Patients with Lupus Nephritis
Deposition of Immune Complexes in Gingival Tissues in the Presence of Periodontitis and Systemic Lupus Erythematosus
Role of biomarkers in the diagnosis and prognosis of patients with cutaneous lupus erythematosus
The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis
Successful treatment of refractory cystitis associated with systemic lupus erythematosus with Belimumab
Transcriptomic studies of systemic lupus erythematosus
Recent Insight on the Management of Lupus Erythematosus Alopecia
COVID-19 Vaccination in Rheumatic Disease Patients
Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus
Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76)
Biologics and systemic lupus erythematosous : new insights and perspectives
Cardiovascular Considerations in Anesthetic Management for a Patient With Antiphospholipid Syndrome and Decreased Cardiac Function: A Case Study
LONG TERM RENAL SURVIVAL OF PEDIATRIC PATIENTS WITH LUPUS NEPHRITIS
Pruritus as a Distinctive Feature of Type 2 Inflammation
Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity
ALPN-101 in Systemic Lupus Erythematosus
Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients
Bilateral periorbital oedema revealed as systemic lupus erythematosus in a young male
An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis
Predictors of renal flares and long-term renal outcome in patients with lupus nephritis: results from daily clinical practice
Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention
Targetoid lesions in a patient with systemic lupus erythematosus
Femoral Head Osteonecrosis in Systemic Lupus Erythematosus: Total Hip Arthroplasty Outcomes and Considerations
CDK4/6 inhibitor palbociclib reduces inflammation in lupus-prone mice
An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases
Anti-TWEAK Antibody Alleviates Renal Interstitial Fibrosis by Increasing PGC-1alpha Expression in Lupus Nephritis
LINC00176 facilitates CD4(+)T cell adhesion in systemic lupus erythematosus via the WNT5a signaling pathway by regulating WIF1
A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology

PECULIARITIES OF BONE MINERAL DENSITY IN WOMEN OF DIFFERENT REPRODUCTIVE AGE WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus
TRIM10 binds to interferon-α/β receptor 1 to negatively regulate type I interferon signal transduction
Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
Respiratory Manifestations in Systemic Lupus Erythematosus
Autoimmune Complications in Hematologic Neoplasms
Erythropoietin Protects against Diffuse Alveolar Hemorrhage in Mice by Regulating Macrophage Polarization through the EPOR/JAK2/STAT3 Axis
Erythropoietin in Lupus: Unanticipated Immune Modulating Effects of a Kidney Hormone
The coexistence of familial Mediterranean fever (FMF) in systemic lupus erythematosus (SLE) patients – A cross sectional study
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study
Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life
Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
Ultrasound to identify SLE patients with musculoskeletal symptoms who respond best to therapy: The USEFUL longitudinal multicentre study
New therapeutic approaches using hydrogen sulfide donors in inflammation and immune-response
Mood Disorder in Systemic Lupus Erythematosus Induced by Antiribosomal P Protein Antibodies Associated with Decreased Serum and Brain Tryptophan
Comparison of responsiveness of BILAG-2004, SLEDAI-2000 and BILAG Systems Tally (BST)
Voclosporin: First Approval
Relevant domains and outcome measurement instruments in Neuropsychiatric Systemic Lupus Erythematosus: a systematic literature review
Pristane-induced mammary carcinomas
Use of (18)F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography to successfully diagnose central nervous system vasculitis in systemic lupus erythematosus and antiphospholipid syndrome: a case report
A case of systemic lupus erythematosus with marked ascites due to idiopathic non-cirrhotic portal hypertension
Nucleic acids delivered by PEGylated cationic liposomes in systemic lupus erythematosus-prone mice: a possible exacerbation of lupus nephritis in the presence of pre-existing anti-nucleic acid antibodies
Case Report: A Fatal Case of West Nile Virus Meningoencephalomyelitis in a Woman with Systemic Lupus Erythematosus Initially Misdiagnosed as SARS-CoV-2 Infection
Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches
Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis
Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity
Atypical arthritis of the hands : Collagenosis-part 1
Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndrome: is drug interaction the culprit?
Cardiac Tamponade during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis and Anti-DNA Antibody Positivity
Winning the Battle after Three Years of Suffering: A Case of a Refractory Pyoderma Gangrenosum Treatment Challenge
Case Report: Kidney Transplantation in a Patient With Acquired Agammaglobulinemia and SLE. Issues and Challenges
Efficacy of allogeneic hematopoietic cell transplantation for autoimmune diseases
Intestinal pseudo-obstruction: Unusual presentation of systemic lupus erythematous
ANTIPHOSPHOLIPID ANTIBODIES DO NOT PREDICT DAMAGE IN SLE PATIENTS IN THE XXI CENTURY. AN OBSERVATIONAL STUDY FROM THE LUPUS-CRUCES COHORT
The Koebner phenomenon on tattoos and piercings in a patient with cutaneous lupus: a case report and review of the literature
Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis
Predictive Biomarker Panel in Proliferative Lupus Nephritis- Two-Dimensional Shotgun Proteomics
Quality Evaluation of the Underlying Evidence in the Updated Treatment Recommendations for Systemic Lupus Erythematosus
Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-gamma-Producing CD8(+) T Cells via STAT6-GATA-3 Axis in Systemic Lupus Erythematosus
Integrated Chinese and western medicine for SLE: A protocol for systematic review and meta-analysis
The effects of disease activity on neuronal and behavioural cognitive processes in systemic lupus erythematosus
miR-101-3p negatively regulates inflammation in systemic lupus erythematosus via MAPK1 targeting and inhibition of the NF-kappaB pathway
Stem Cell Therapy as a Treatment for Autoimmune Disease-Updates in Lupus, Scleroderma, and Multiple Sclerosis
An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus
Overlap syndrome SLE – ANCA associated vasculitis
Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea
4-phenylbutyric acid mediates therapeutic effect in systemic lupus erythematosus: Observations in an experimental murine lupus model
What’s New in the Treatment of Systemic Lupus Erythematosus
Difference of IFI44L methylation and serum IFN-a1 level among patients with discoid and systemic lupus erythematosus and healthy individuals
S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-alpha) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases
Study of GS-5718 in Participants With Cutaneous Lupus Erythematosus (CLE)
Negativization of antinuclear, anti-dsDNA, and anti-chromatin antibodies after vitamin D supplementation in a lupus patient
Machine Learning for Prediction and Risk Stratification of Lupus Nephritis Renal Flare
Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort
Systemic lupus erythematosus
Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model
Catastrophic antiphospholipid syndrome presented as ruptured papillary muscle during puerperium in a patient with systemic lupus erythematosus
Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
Development of Prediction Models for New Integrated Models and a Bioscore System to Identify Bacterial Infections in Systemic Lupus Erythematosus
DOAC-Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
Clinical-therapeutic study on the efficacy and safety of thalidomide in the management of discoid lupus erythematosus. A single-centre, retrospective study
Very Severe and Refractory Noninfectious Cystitis in Patients with Systemic Lupus Erythematosus: Potential Role of Rituximab Therapy
Multiple neurological manifestations in a patient with systemic lupus erythematosus and anti-NXP2-positive myositis: A case report
Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus
SARS-CoV-2 vaccines in patients with SLE
Hydroxychloroquine: An Old Drug With New Tricks
Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE-data from the BSR audit of systemic lupus erythematosus
Deescalation and glucocorticoid-free treatment in SLE
Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice
NK1.1(-) natural killer T cells upregulate interleukin-17 expression in experimental lupus nephritis
Infratentorial onset of progressive multifocal leukoencephalopathy in a patient with systematic lupus erythematosus complicated with lymphoma: a case report
Systemic lupus erythematosus and COVID-19 during pregnancy
Anal cancer and precancerous lesions: a call for improvement
Implementing the DEcision-Aid for Lupus (IDEAL): study protocol of a multi-site implementation trial with observational, case study design : Implementing the DEcision-Aid for Lupus
Adrenal steroidogenesis and ovarian reserve in adult childhood-onset systemic lupus erytematosus patients
Monogenic Lupus with IgA Nephropathy Caused by Spondyloenchondrodysplasia with Immune Dysregulation
Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus
A novel JAK/ROCK inhibitor, CPL409116, demonstrates potent efficacy in the mouse model of systemic lupus erythematosus
Hepatitis E Viral Association with Autoimmune Hepatitis: A Viral Trigger or Cross-Reactivity
Papulopustular and Ocular Rosacea with an Alleged Coincidence of Cutaneous Lupus Erythematosus: A Case Report
Collapsing FSGS with Concurrent Class 2 and 3 Lupus Nephritis: A Case Report and Review of the Literature
Low-Vacuum Scanning Electron Microscopy to Assess Histopathological Resolution of Class V Lupus Nephritis: A Case Report
Interleukin (IL)-1 family cytokines could differentiate primary immune thrombocytopenia from systemic lupus erythematosus-associated thrombocytopenia
Anti-TNF-alpha-induced lupus syndrome : Two case reports and review of current literature
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study
Amino Acid Metabolism in Lupus
Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study
Eculizumab therapy on a patient with co-existent lupus nephritis and C3 mutation-related atypical haemolytic uremic syndrome: a case report
Systemic Lupus Erythematosus and COVID-19
Interventions for cutaneous disease in systemic lupus erythematosus
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar() Gel) for Persistently Active Systemic Lupus Erythematosus
Patient Experience With Fatigue and Qualitative Interview-Based Evidence of Content Validation of The FACIT-Fatigue in Systemic Lupus Erythematosus
Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
Prognostic significance of hypertension at the onset of lupus nephritis in Chinese patients: prevalence and clinical outcomes
Subepithelial Autoimmune Bullous Dermatoses Disease Activity Assessment and Therapy
Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives
Revised ISN/RPS 2018 classification of lupus renal pathology predict clinical remission
Kikuchi-Fujimoto Disease: Report of a Case with Progression to Lupus Nephritis

The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia
Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation
Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE
Circulating Free DNA and Its Emerging Role in Autoimmune Diseases
Lipidomics Revealed Aberrant Metabolism of Lipids Including FAHFAs in Renal Tissue in the Progression of Lupus Nephritis in a Murine Model
CX3CR1 might be a promising predictor of systemic lupus erythematosus patients with pulmonary fibrosis
Gastrointestinal and hepatic involvement in paediatric systemic lupus erythematosus
Severe Vaso-Occlusive Retinopathy in Systemic Lupus Erythematosus: A Case Series
The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion
Medium versus high initial prednisone dose for remission induction in lupus nephritis: A propensity score matched analysis
Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus
Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls
One-year prospective nerve conduction study of thalidomide neuropathy in lupus erythematosus: Incidence, coasting effect and drug plasma levels
Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)
RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin
A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis
Severe pulmonary arterial hypertension and massive ascites in a patient with systemic lupus erythematosus and secondary Sjogren’s syndrome
Cutaneous Lupus Erythematosus In Children
Treatment of exostosin 1-associated membranous lupus nephritis with multiple low doses of rituximab: A case report
Pyoderma gangrenosum and cobalamin deficiency in systemic lupus erythematosus: a rare but non fortuitous association
Roles of leptin on the key effector cells of rheumatoid arthritis
Renal tubular distal acidosis: nephrocalcinosis as initial diagnosis.
Psychopathology in paediatric systemic lupus erythematosus
Medication adherence of patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Considering the Psychosocial Factors, Health Literacy and Current Life Concerns of Patients
Evolution of kidney antibody secreting cells molecular signature in lupus patients with active nephritis upon immunosuppressive therapy
Two shared immune cell signatures stratify patients with Sjogren’s syndrome and systemic lupus erythematosus with potential therapeutic implications
Exploiting Rational Assembly to Map Distinct Roles of Regulatory Cues during Autoimmune Therapy
HLA-DRB1(*)04 as a Risk Allele to Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of Malaysia
Downregulated Serum Exosomal miR-451a Expression Correlates With Renal Damage and Its Intercellular Communication Role in Systemic Lupus Erythematosus
Pneumocystis jirovecii pneumonia in systemic lupus erythematosus: a nationwide cohort study in Taiwan
Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?
A novel potential target of IL-35-regulated JAK/STAT signaling pathway in lupus nephritis
Niclosamide suppresses the expansion of follicular helper T cells and alleviates disease severity in two murine models of lupus via STAT3
Resolution of calcinosis using bisphosphonates in overlap syndrome – a case report
Interferon alpha Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus
Case Report: Complete Remission of C1q Nephropathy Treated With a Single Low-Dose Rituximab, a Reality or Coincidence?
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers
Belimumab for systemic lupus erythematosus
Belimumab: a step forward in the treatment of systemic lupus erythematosus
Novel signatures associated with systemic lupus erythematosus clinical response to IFN-alpha/-omega inhibition
Severe retinal vasculitis in systemic lupus erythematosus leading to vision threatening paracentral acute middle maculopathy
Patient and provider perceptions of a novel cognitive functioning report for patients with systemic lupus erythematosus: a qualitative study
Atypical Presentation of Pediatric Systemic Lupus Erythematosus Complicated by Cryptococcal Meningitis
Extracorporeal cardiopulmonary resuscitation for the treatment of amlodipine overdose in a pediatric patient
A Fatal Case of Diffuse Alveolar Hemorrhage in the Setting of Systemic Lupus Erythematosus: A Case Report and Review of Noninfectious Causes of Acute Pulmonary Hemorrhage in Adults
An integrated analysis of lncRNA and mRNA expression profiles in the kidneys of mice with lupus nephritis
Psychosis in Systemic Lupus Erythematosus (SLE): 40-year experience of a specialist centre
“It is good to have a target in mind”: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE
Exposure-Response Analysis for Selection of Optimal Dosage Regimen of Anifrolumab in Patients With Systemic Lupus Erythematosus
Seizures in systemic lupus erythematosus: A scoping review
A Systematic Review of the Literature on Systemic Lupus Erythematosus
Actinic cheilitis may resemble oral lichenoid-type lesions or discoid lupus erythematosus
Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus
Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report
Perioperative Management of Rheumatic Disease and Therapies
Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome
Assessment of SLE activity for acute clinical decision-making: use of a colour-coded threat-level approach for the non-rheumatologist
Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function
Novel biomarkers for lupus nephritis in the “OMICS” era
Improvement of lupus-associated fatigue with modafinil: Report of two cases
Managing Cardiovascular Risk in Patients with Rheumatic Disease
NOD-like receptors in autoimmune diseases
A case of Stappia indica-induced relapsing peritonitis confirmed by 16S ribosomal RNA gene sequencing analysis in a patient undergoing continuous ambulatory peritoneal dialysis
Long-term therapeutic effects of multi-target therapy in a patient with membranous lupus nephritis: An interesting repeat kidney biopsy case
Triamcinolone
Elevated urinary IL-36gamma in patients with active lupus nephritis and response to treatment
Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis
Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials
Black-blood magnetic resonance imaging suggesting central nervous system vasculitis in moyamoya syndrome associated with systemic lupus erythematosus
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study
Discoid lupus erythematosus solely involving the eyelids: case report and literature review
Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme
Systemic Lupus Erythematosus in Children and Young People
Intracranial hypertension secondary to systemic lupus erythematosus
Safety considerations when using drugs in pregnant patients with systemic lupus erythematosus
Management of Lupus Nephritis
Role of Microneedling in Atrophic Post-Acne Scars: An Experience from a Tertiary Care Hospital
Effect of plasma exosomes on endothelial cell tight junction proteins in SLE patients with immune thrombocytopenia
Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons – California, 2007-2017
Systemic Lupus Erythematosus and Its Association with Hemophagocytic Syndrome as an Initial Manifestation
A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Fas(lpr) mice with proliferative lupus nephritis predicts low effect size
Sexual dimorphism in immunometabolism and autoimmunity: Impact on personalized medicine
Clinical characteristics and CT manifestations of invasive pulmonary aspergillosis in hospitalised patients with systemic lupus erythematosus
Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis
Breastfeeding in women affected by systemic lupus erythematosus: Rate, duration and associated factors
Anti-glomerular Basement Membrane Disease with Antiphospholipid Syndrome
Duration of antibiotic therapy in systemic lupus erythematosus patients with hospital-acquired bacterial pneumonia in eastern China
Patchy Alopecia in a Patient with Rheumatoid Arthritis: A Practical Application of Trichoscopy
Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE)
Sudden visual loss in a patient with systemic lupus erythematosus caused by a combination of the disease itself and drug toxicity.
Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 Epidemic.
[Therapeutic de-escalation in systemic lupus erythematosus in remission].
Evolution of COVID-19 in patients with autoimmune rheumatic diseases.
Neonatal lupus presenting as a non-specific rash in primary care.
Non-central serous chorioretinopathy in a patient with systemic lupus erythematosus and hydroxychloroquine retinopathy.
[Effects of the COVID-19 quarantine on patients with rheumatoid arthritis and systemic lupus erythematosus].
Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis.
Breastfeeding in women affected by systemic lupus erythematosus: Rate, duration and associated factors.

Anti-glomerular Basement Membrane Disease with Antiphospholipid Syndrome.
Patchy Alopecia in a Patient with Rheumatoid Arthritis: A Practical Application of Trichoscopy.
Toll-Like Receptors Regulate the Development and Progression of Renal Diseases.
Duration of antibiotic therapy in systemic lupus erythematosus patients with hospital-acquired bacterial pneumonia in eastern China.
Sexual and mental health of woman suffering from selected connective tissue diseases: an original paper.
Clinical characteristics and CT manifestations of invasive pulmonary aspergillosis in hospitalised patients with systemic lupus erythematosus.
Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: result of the COVID-19-GEAS patient survey.
Pemphigus Erythematosus: A Case Series from A Tertiary Academic Center and Literature Review.
Sexual dimorphism in immunometabolism and autoimmunity: Impact on personalized medicine.
Serine Phosphorylation of the STAT1 Transactivation Domain Promotes Autoreactive B Cell and Systemic Autoimmunity Development.
Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus.
Antiphospholipid antibodies in patients with coronavirus disease 2019 infection hospitalized in conventional unit.
Systemic Lupus Erythematosus and Its Association with Hemophagocytic Syndrome as an Initial Manifestation.
Adult-diagnosed Chronic Granulomatous Disease: The Need to Increase Awareness.
A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Faslpr mice with proliferative lupus nephritis predicts low effect size.
Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn’s Disease.
Elevated urinary IL-36γ in patients with active lupus nephritis and response to treatment.
Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis.
Black-blood magnetic resonance imaging suggesting central nervous system vasculitis in moyamoya syndrome associated with systemic lupus erythematosus.
Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement.
Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis.
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review.
Improvement of lupus-associated fatigue with modafinil: Report of two cases.
IRF5 inhibitor shows promise in mouse models of SLE.
Managing Cardiovascular Risk in Patients with Rheumatic Disease.
NOD-like receptors in autoimmune diseases.
Efficacy of moderately dosed etoposide in macrophage activation syndrome – hemophagocytic lymphohistiocytosis (MAS-HLH).
A case of Stappia indica-induced relapsing peritonitis confirmed by 16S ribosomal RNA gene sequencing analysis in a patient undergoing continuous ambulatory peritoneal dialysis.
Long-term therapeutic effects of multi-target therapy in a patient with membranous lupus nephritis: An interesting repeat kidney biopsy case.
Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.
Treat-to-target in systemic lupus erythematosus: Where are we?
Foreign body episcleral suture granulomas mimicking nodular anterior scleritis.
CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS
Association between Optic Neuritis and Inflammatory Bowel Disease: A Population-Based Study.
Management of Lupus Nephritis.
Role of Microneedling in Atrophic Post-Acne Scars: An Experience from a Tertiary Care Hospital.
Neonatal lupus erythematosus presenting with rash, thrombocytopenia compounded by cytomegalovirus colonisation: a diagnostic dilemma.
Acute lupus pneumonitis as the initial presentation of systemic lupus erythematosus.
[Thrombocytopenia and thromboses in a young woman].
Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower.
UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE.
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus.
Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme.
[Intracranial hypertension secondary to systemic lupus erythematosus].
Systemic Lupus Erythematosus in Children and Young People.
Expanding the Role of Complement Therapies: The Case for Lupus Nephritis.
Advances in Membranous Nephropathy.
All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database.
Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus Erythematosus.
Lupus manifestations in children with primary immunodeficiency diseases: Comprehensive phenotypic and genetic features and outcome.
Acute Tracheal Necrosis After Intubation in a Childhood Onset Systemic Lupus Erythematosus.
The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research.
Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study.
Medication adherence: a qualitative exploration of the experiences of adolescents with systemic lupus erythematosus.
Complications of tuberculous meningitis in magnetic resonance imaging in a patient with systemic lupus erythematosus.
γ heavy chain disease presenting in a patient with systemic lupus erythematosus.
[Application and safety of hydroxychloroquine in chronic disease among children].
Kingella kingae Intrauterine Infection: An Unusual Cause of Chorioamnionitis and Miscarriage in a Patient with Undifferentiated Connective Tissue Disease.
Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus.
Lupus miliaris disseminatus faciei with complete response to isotretinoin.
Early predictors of renal outcome in patients with proliferative lupus nephritis: a 36-months cohort study.
Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in a 77-year-old man: A case report.
Natural killer cells in inflammatory autoimmune diseases.
Long-term Health Consequences of Endometriosis – Pathways and Mediation by Treatment.
Characteristics and Outcomes of Critically Ill Pediatric Patients with Posterior Reversible Encephalopathy Syndrome.
Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples.
The glycocalyx presents a sweet new target in lupus nephritis.
Adding belimumab improves lupus nephritis.
SARS-CoV-2 and Systemic Lupus Erythematosus.
Mitral Valve Repair for Isolated Libman-Sacks Endocarditis in a Patient with Primary Antiphospholipid Syndrome.
[An updated advance of autoimmune hepatitis in children].
Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model.
Predictors of Initial Hydroxychloroquine Receipt among Medicaid Beneficiaries with Incident Systemic Lupus Erythematosus.
Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort.
Taurine attenuates the damage of lupus nephritis mouse via inactivation of the NF-κB pathway.
Hypertension in a patient with medullary sponge kidney: A case report.
Childhood-Onset Systemic Lupus Erythematosus: Southeast Asian Perspectives.
Safety and clinical activity of atacicept in the long-term extension of the Phase IIb ADDRESS II study in systemic lupus erythematosus.
Predominant tubulointerstitial lupus nephritis with preceding pernicious anemia.
Vagus nerve stimulation in musculoskeletal diseases.
Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy.
Chloroquine: autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?
SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link?
Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus.
Socioeconomic status at diagnosis influences the incremental direct medical costs of systemic lupus erythematosus: A longitudinal population-based study.
Advances in ANCA-associated vasculitis and lupus nephritis.
Are new treatments for lupus nephritis on the horizon?
BLISS in the Treatment of Lupus Nephritis.
Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups.
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified Lupus.
Pentacyclic triterpene compounds from loquat leaves reduce skin inflammation and epidermal hyperplasia in psoriasis via inhibiting the Th17 cells.
Ureteritis associated with systemic lupus erythematosus: a case report.
Freiberg’s Infarction as the First Clinical Presentation of Sneddon Syndrome.
[Epstein-Barr virus (Herpesviridae: Gammaherpesvirinae: Lymphocryptovirus: Human gammaherpesvirus 4): replication strategies].
Initial Hydroxychloroquine Monotherapy in Systemic Lupus Erythematosus: Report of Three Cases.
Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults.
B Cell Aberrance in Lupus: the Ringleader and the Solution.
Sirolimus Treatment Of Patients With SLE
Medication Adherence in Chinese Patients With Systemic Lupus Erythematosus.

Sleep quality and clinical and psychological manifestations in women with mild systemic lupus erythematosus activity compared to women with fibromyalgia: A preliminary study.
B cell-intrinsic TLR9 expression is protective in murine lupus.
E4BP4-mediated inhibition of T follicular helper cell differentiation is compromised in autoimmune diseases.
Risk factors for severity of thrombocytopenia in full term infants: a single center study.
Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro.
Outcome of clinical and subclinical myocardial injury in systemic lupus erythematosus – A prospective cohort study.
Voclosporin: a novel calcineurin inhibitor without impact on mycophenolic acid in patients with SLE.
The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis.
Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series.
Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study.
Autoimmune polyendocrine syndrome type 4 with systemic lupus erythematosus and anti-phospholipid syndrome.
Functional Lipids in Autoimmune Inflammatory Diseases.
Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
Surgical repair of a giant pulmonary artery aneurysm that caused severe left bronchial obstruction.
Impact of Limited Health Literacy on Patient-Reported Outcomes in Systemic Lupus Erythematosus.
Clinical Team Perspectives on the Psychosocial Aspects of Transition to Adult Care for Patients With Childhood-Onset Systemic Lupus Erythematosus.
Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications.
Recent Advances in Lupus B Cell Biology: PI3K, IFNγ, and Chromatin.
Concomitant primary hyperparathyroidism and systemic lupus erythematosus: coincidence or not? A new case report.
Survey of coyotes, red foxes and wolves from Wyoming, USA, for Echinococcus granulosus s. l.
Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: a case series.
Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis.
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.
Hydroxychloroquine in systemic and auto-immune diseases: where are we now?
Belimumab in Lupus Nephritis.
Belimumab in Lupus Nephritis.
Belimumab in Lupus Nephritis. Reply.
Pediatric systemic lupus erythematosus with lupus anticoagulant hypoprothrombinemia syndrome-A case series with review of literature.
Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist.
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group.
Improving medication adherence in patients with lupus nephritis.
Induction and maintenance therapy of lupus nephritis: an obituary.
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.
NETosis in Rheumatic Diseases.
Post-translational modifications in T cells in systemic erythematosus lupus.
T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update.
[Belimumab as add-on treatment in lupus nephritis (summary of the BLISS-LN trial)].
[Systemic lupus erythematosus].
Synergetic Interaction of HLA-DRB1*07 Allele and TNF-Alpha - 863 C/A Single Nucleotide Polymorphism in the Susceptibility to Systemic Lupus Erythematosus.
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease.
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications.
Scleroderma Renal Crisis in a Case of Mixed Connective Tissue Disease Treated Successfully with Angiotensin-Converting Enzyme Inhibitors.
A Case of Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis Overlap Syndrome.
Association between MRI findings and patient-reported outcomes in patients with rheumatoid arthritis in clinical remission and at relapse.
Hydralazine induced lupus nephritis after prolonged exposure.
Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis-Translation of Pathogenic Fundamentals Into an In Vitro Model.
Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus.
[Rheumatology update 2020: the focus was on Covid-19].
Multiple pathways of type 1 interferon production in lupus: the case for amlexanox.
A New Peracetylated Oleuropein Derivative Ameliorates Joint Inflammation and Destruction in a Murine Collagen-Induced Arthritis Model via Activation of the Nrf-2/Ho-1 Antioxidant Pathway and Suppression of MAPKs and NF-κB Activation.
EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE
Lupus in the 21st century.
Lupus nephritis: clinical presentations and outcomes in the 21st century.
Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus.
Adverse Reactions Induced by Minocycline: A Review of Literature.
Systemic lupus erythematosus manifestation following COVID-19: a case report.
QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine.
Legionella pneumophila as a cause of cavitary lung disease in systemic lupus erythematous.
Resolution of huge thrombi in bilateral ventricles caused by severe lupus cardiomyopathy.
Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine.
Use of a Modified Classic BT Shunt in a Patient With Multiple Conduit Obstructions With Positive Lupus Anticoagulant.
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.
Lupus versus dermatomyositis: the hands say it all.
Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
Mathematical processing is affected by daily but not cumulative glucocorticoid dose in patients with systemic lupus erythematosus.
Pentraxin 3: A promising therapeutic target for autoimmune diseases.
Numbness and Weakness in a Patient With Systemic Lupus Erythematosus.
SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression.
Vogt-Koyanagi-Harada Disease and Systemic Lupus Erythematosus Occurring during Adalimumab Therapy for Ulcerative Colitis.
Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery in Clinic.
Transcatheter Aortic Valve Implantation in Patients with Connective Tissue Disease.
Emerging B-Cell Therapies in Systemic Lupus Erythematosus.
Stage one adenocarcinoma of uterine cervix in a patient with systemic lupus erythematosus – a clinical case.
From TTP to Glomerulonephritis: A Lifetime of Lupus.
Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide.
Tofacitinib-induced subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis.
Prognostic analysis of antibody typing and treatment for antiphospholipid syndrome-related recurrent spontaneous abortion.
Remission in SLE-do DORIS criteria match the treating physician’s judgment? A cross sectional study to assess reasons for discordance.
Algorithm for calculating high disease activity in SLE.
Genome-wide association study on Northern Chinese identifies KLF2, DOT1L and STAB2 associated with systemic lupus erythematosus.
Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy.
Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2-3 mg/kg/day): 12-month prospective randomized controlled trial.
Lupus erythematosus: Significance of dermatologic findings.
Subacute cutaneous lupus erythematosus induced by PD-1 Inhibitor therapy: two case reports and literature review.
Longitudinally Extensive Transverse Myelitis in a Lupus-Neuromyelitis Optica Overlap.
Tubercular meningitis in patients with systemic lupus erythematosus: clinical characteristics, risk factors, and outcomes of 10 patients.
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
Tuberculous arthritis of the ankle joint masquerading as rheumatoid arthritis in a patient with lupus nephritis.
PREVALENCE OF THE ABCB1-1Δ GENE IN NONDOMESTIC SPECIES OF THE CANIDAE FAMILY.
Membranous nephropathy: current understanding of various causes in light of new target antigens.
Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets.
Cryopreservation of Grey Wolf (Canis lupus) Testicular Tissue.
Efficacy of Intense Pulsed Light in the Treatment of Facial Telangiectasia in Systemic Lupus Erythematosus
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
Negative Pressure Wound Therapy With Instillation and Dwell Time Used to Treat Pyoderma Gangrenosum: A Case Report.
Risk Factors for Short-Term Complication After Open Reduction and Internal Fixation of Ankle Fractures: Analysis of a Large Insurance Claims Database.
Juvenile-onset multifocal osteonecrosis in systemic lupus erythematosus: A case report.
Successful treatment of subdural hemorrhage and retinal hemorrhage in childhood-onset systemic lupus erythematosus associated with thrombocytopenia: Case report.

Dihydroartemisinin attenuated the symptoms of mice model of systemic lupus erythematosus by restoring the Treg/Th17 balance.
Mitral Valve Mass in a Patient Suspected of Systemic Lupus: Tumor, Endocarditis or Both?
Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
Neonatal lupus erythematosus – practical guidelines.
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry.
Persistent deficiency of mucosal-associated invariant T cells during dermatomyositis.
Young-Onset Ischemic Colitis: A Condition of Elusive Etiology Frequently Associated With Immune Dysregulation.
Clinical characteristics of systemic lupus erythematosus with chylothorax and/or chylous ascites: An analysis of 15 cases in China.
Subacute cutaneous lupus erythematosus in a patient with Sjögren’s syndrome taking terbinafine for onychomycosis.
Maternal and Fetal Outcomes in Systemic Lupus Erythematosus Pregnancies.
Refractory dermatomyositis-systemic lupus erythematosus overlap syndrome and response to tofacitinib.
Alkaline-Encrusted Pyelitis Causing Renal Failure in a Transplant Kidney: Treatment with Percutaneous Nephrolithotomy and Urinary Acidification.
Retrospective Analysis of the Factors Affecting Growth Parameters in Turkish Children With Systemic Lupus Erythematosus.
Rituximab – The first twenty years.
When POTS is the tip of the iceberg: Rare cases of dysautonomia as a possible manifestation of another disorder.
Concomitant Diagnosis of Fibromyalgia and Ankylosing Spondylitis: Relation to Clinical Features and Plasma Pentraxin -3 Level.
Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa.
New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE.
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’.
Clinical improvement of cardiac function in a patient with systemic lupus erythematosus and heart failure with preserved ejection fraction treated with belimumab.
The readiness of pediatric rheumatology patients and their parents to transition to adult-oriented treatment.
Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?
Response to: ‘Patients with lupus are not protected from COVID-19: a comment’ by Sawalha, ‘No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit’ by Romão et al and ‘SLE patients are not immune to COVID-19: importance of sending the right message across’ by Goyal.
MAIT cells, their biological and medical significance.
Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum Hutch.
The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
Concentrated autologous bone marrow aspirate transplantation versus conservative treatment for corticosteroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.
Lupus podocytopathy: a newly emerging nonimmune complex mediated nephropathy associated with systemic lupus erythematosus.
Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparison.
Cytomegalovirus in Indian systemic lupus erythematosus patients: troublemaker or onlooker?
Limbic encephalitis in a patient with systemic lupus erythematosus successfully treated with high-dose glucocorticoids and intravenous cyclophosphamide therapy: the potential pathogenicity of anti-glutamate receptor antibodies.
Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia.
Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases.
Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare.
How a discerning cytological examination can aid in the diagnosis of infectious diseases: case reports.
Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars
Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus.
Tumoral calcinosis in systemic lupus erythematosus associated with fat necrosis.
[Clinical Features and Risk Factors of Systemic Lupus Erythematosus Complicated with Cytomegalovirus Infection].
Childhood granulomatous periorificial dermatitis: case report and review of the literature.
The role of Stim1 in the progression of lupus nephritis in mice.
New findings associated with presumptive systemic lupus erythematosus in a kitten.
Porphyria cutanea tarda exacerbation as a paraneoplastic syndrome in vaginal cancer resolved with chemoradiation.
Prevalence of osteoporosis in patients with systemic lupus erythematosus: A multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria.
Formulation and stability study of hydroxychloroquine sulfate oral suspensions.
[Toxic hydroxychloroquine-induced cardiomyopathy complicating systemic lupus treatment].
The impact of autoimmune systemic inflammation and associated medications on male reproductive health in patients with chronic rheumatological, dermatological, and gastroenterological diseases: A systematic review.
Electron microscopy study of 496 cases of lupus nephritis: A single-center experience.
A novel therapeutic approach using the Zipper method to treat chorea in a pediatric-onset systemic lupus erythematosus patient.
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK.
How do systemic lupus erythematosus patients with very-long disease duration present? Analysis of a monocentric cohort.
Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine.
RITUXILUP Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
Risk factors associated with adverse pregnancy outcomes in patients with new-onset systemic lupus erythematosus during pregnancy.
Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.
Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review.
Transplantation-mediated alloimmune thrombocytopenia successfully treated by retransplantation.
Successful treatment of severe interstitial pneumonia by removal of circulating autoantibodies: a case series.
Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy.
Current status of use of high throughput nucleotide sequencing in rheumatology.
Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine.
Inhibition of B cell activation following in vivo co-engagement of B cell antigen receptor and Fcγ receptor IIb in non-autoimmune-prone and SLE-prone mice.
Interferon-directed therapies for the treatment of systemic lupus erythematosus: a critical update.
COVID-19, rheumatic diseases and immune dysregulation-a perspective.
The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases.
Consequences of insurance denials among U.S. patients prescribed repository corticotropin injection (Acthar® Gel) for nephrotic syndrome.
Impact of Antimalarial Adherence on Mortality among Patients with Newly Diagnosed Systemic Lupus Erythematosus: A Population-based Cohort Study.
The complex relationship between C4b Binding Protein, warfarin and antiphospholipid antibodies.
A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus
Low ambient temperature increases hospital re-admissions for systemic lupus erythematosus in humid subtropical region: a time series study.
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus.
A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients.
The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.
D-mannose ameliorates autoimmune phenotypes in mouse models of lupus.
Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.
Higher Hydroxychloroquine Blood Levels Are Associated with Reduced Thrombosis Risk in Systemic Lupus Erythematosus.
A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting.
Refractory palmo-plantar Discoid Lupus Erythematosus successfully treated with Mycophenolate Mofetil: unusual localization and literature review.
Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren’s syndrome or systemic lupus erythematosus.
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week long therapy in patients with SLE.
Ileocolic intussusception caused by mass-forming fibro-granulation from healed ulcer masquerading as small bowel lipoma.
[Advances in induction therapy drugs of lupus nephritis for children].
Generation of systemic lupus erythematosus patient-derived induced pluripotent stem cells from blood.
Patient and parent perspectives on transition from paediatric to adult healthcare in rheumatic diseases: an interview study.
Immune Cell-Stromal Circuitry in Lupus Photosensitivity.
[Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up].
Modular gene analysis reveals distinct molecular signatures for cutaneous lupus patient subsets.
B cell depletion in murine lupus using cytotoxic T lymphocytes in vivo: Feasibility and benefit.
B7-H3: A promising therapeutic target for autoimmune diseases.
Anti-CD2 Antibody-Coated Nanoparticles Containing IL-2 Induce NK Cells That Protect Lupus Mice via a TGF-β-Dependent Mechanism.
Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data.
Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
The Effect of Mycophenolate Mofetil as First-Line Therapy on the Timing of Urine Protein-to-Creatinine Ratio Reduction in Immunosuppressant-Naive Patients With Lupus Nephritis at a Single Center.
Immunotherapies application in active stage of systemic lupus erythematosus in pregnancy: A case report and review of literature.
Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus.

Predicting lupus flares: epidemiological and disease related risk factors.
The latest in systemic lupus erythematosus-accelerated atherosclerosis: related mechanisms inform assessment and therapy.
Cellular aspects of the pathogenesis of lupus nephritis.
Mobile health technologies for the management of rheumatic diseases: a systematic review of online stores in Brazil.
COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.
Rosai-Dorfman-Destombes Disease as First Manifestation of Systemic Lupus Erythematosus.
Spermatic vein thrombosis with lupus anticoagulant, a cause of acute inguinal pain: a case report.
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant.
Anti-neutrophil properties of natural gingerols in models of lupus.
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
National Analysis of Coronary Artery Bypass Grafting in Autoimmune Connective Tissue Disease.
Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach.
Discovery of BIIB068: A Selective, Potent, Reversible Bruton’s Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases.
COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration.
A Peculiar Case of Small Bowel Stricture in a Coronavirus Disease 2019 Patient with Congenital Adhesion Band and Superior Mesenteric Vein Thrombosis.
Innovative use of concentrated growth factors combined with corticosteroids to treat discoid lupus erythematosus alopecia: A case report.
From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markers.
Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review.
Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis.
IL-23/IL-17 axis in the pathogenesis and treatment of systemic lupus erythematosus and rheumatoid arthritis.
Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment.
Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment.
Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders.
Predictors of unsuccessful hydroxychloroquine tapering and discontinuation: Can we personalize decision-making in systemic lupus treatment?
Beta Cell Function is Disrupted in Patients with Systemic Lupus Erythematosus.
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2.
Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms.
Evaluation of corneal safety in systemic lupus erythematosus patients undergoing long-term hydroxychloroquine treatment.
Total Glucosides of Peony Protect Cardiomyocytes against Oxidative Stress and Inflammation by Reversing Mitochondrial Dynamics and Bioenergetics.
Clinical Observation of COVID-19 in a Patient With an Acquired Humoral Deficiency Secondary to Chemotherapeutic Agents.
COVID-19 in children treated with immunosuppressive medication for kidney diseases.
Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus
Antithyroid Drug-Induced Lupus Erythematosus and Immunoglobulin A Deficiency.
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform.
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
Safety, Tolerability, and Pharmacokinetics of PF-06823859, an Anti-Interferon β Monoclonal Antibody: A Randomized, Phase I, Single- and Multiple-Ascending-Dose Study.
Oxidative stress-induced aberrant lipid metabolism is an important causal factor for dysfunction of immunocytes from patients with systemic lupus erythematosus.
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus.
Belimumab in lupus nephritis.
Linear cutaneous lupus erythematosus in children-report of two cases and review of the literature: A case report.
Understanding patient-provider discordance in adolescents with lupus: The role of pain and antidepressant medication use.
The Effect of Biological Agents on Antinuclear Antibody Status in Patients with Psoriasis: A Single-Center Study.
Secondary Membranous Nephropathy. A Narrative Review.
Childhood Systemic Lupus Erythematosus; a Rare Multisystem Disorder: Case Report of a 3-year-old Girl with Oral Involvement as a Primary Sign.
Successful hydroxychloroquine treatment in a patient with systemic lupus erythematosus-associated nailfold capillary abnormalities.
Systemic lupus erythematosus symptom clusters and their association with patient-reported outcomes and treatment: Analysis of real-world data.
STING-dependent induction of lipid peroxidation mediates intestinal ischemia-reperfusion injury.
De novo lupus nephritis during treatment with belimumab.
Bilateral ear lobe infiltration: an unusual presentation of lupus vulgaris.
Erratum to 16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends.
Liquid Chromatographic Methods for COVID-19 Drugs, Hydroxychloroquine and Chloroquine.
Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double-blind Phase Ib study.
Basophils and IgE contribute to Mixed Connective Tissue Disease development.
Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases.
CD95/Fas and metastatic disease: What does not kill you makes you stronger.
Kikuchi-Fujimoto disease preceded by lupus erythematosus panniculitis: do these findings together herald the onset of systemic lupus erythematosus?
CD74 auto-antibodies display little clinical value in Chinese Han population with axial spondyloarthritis.
Glomerular Disease and Pregnancy.
Discovery of M5049: A Novel Selective TLR7/8 Inhibitor for Treatment of Autoimmunity.
VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism.
Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function.
Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells.
IL-Y Aggravates Murine Chronic Graft-Versus-Host Disease by Enhancing T and B Cell Responses.
New therapeutic approaches in systemic lupus erythematosus.
B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE).
Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.
Xanthogranulomatous pleuritis – An unusual presentation of tuberculosis.
Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
Cryptococcemia According to Immune Status: An Analysis of 65 Critical Cases.
Hepatocellular adenoma(s) arising in nodular regenerative hyperplasia in a patient with systemic lupus erythematosus.
Coxiella burnetii Endocarditis in a Patient with Systemic Lupus Erythematosus: A Case Report of a Diagnostic Challenge.
Neutrophil Activation and Neutrophil Extracellular Trap Formation in Dialysis Patients.
Comparison of effectiveness of topical Tacrolimus 0.1% vs topical Halobetasol Propionate 0.05% as an add-on to oral Hydroxychloroquine in Discoid Lupus Erythematosus.
The place of sphingosine-1-phosphate modulators in the therapy of inflammatory bowel diseases
Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: a Danish nationwide cohort study.
Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study.
Effects and interferences of emicizumab, a humanized bispecific antibody mimicking activated factor VIII cofactor function, on lupus anticoagulant assays.
Therapeutic effects of soluble human leukocyte antigen G2 isoform in lupus-prone MRL/lpr mice.
Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014.
Primary Sjögren’s Syndrome and Cardiovascular Disease.
Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
Application of the 2019 European League Against Rheumatism/American College of Rheumatology systemic lupus erythematosus classification criteria in clinical practice: a single center experience.
Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden.
What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
Extraction of DNA from plastinated tissues.
Elective Termination of Pregnancy in Autoimmune Rheumatic Diseases: Experience From Two Databases.
Peripheral B Cell Subsets in Autoimmune Diseases: Clinical Implications and Effects of B Cell-Targeted Therapies.
Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases.
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay.
Lupus nephritis-related issues during COVID-19 pandemic quarantine.
Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A1 in patients with lupus nephritis.
Tocilizumab and its usage for skin diseases.
Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries.
Lung Cancer Survival in Patients With Autoimmune Disease.
Reduction in SLEDAI is associated with improved arterial stiffness in systemic lupus erythematosus.
CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritis.